Identification of a previously unknown function of adipose tissue in insulin secretion.
Scientists at Helmholtz Munich and the University of Augsburg have made an important breakthrough in better understanding early processes in the development of…
Type 2 diabetes disease progression and successful intervention depend on individual’s unique clinical, genetic, genomic, and environmental information partly represented by gene expression patterns. An international team of researchers around…
The key objective of this proposal was to further dissect and characterize the cell-specific neuroendocrine signaling mechanisms that underlie the development of obesity, diabetes, and their co-morbidities, with a special emphasis on hypothalamic…
Timo Müller and his team have been working for many years on the development of new therapeutic options for diabetes and obesity. Among other things, they decoded a brain receptor that plays a crucial role in the regulation of body weight and food…
Prof. Cristina García-Cáceres (second left) receives the DAG research award 2022 for her scientific contribution in the field of obesity research. The prize, she shares with Dr. Anne Lautenbach from the University Clinic Hamburg-Eppendorf, was…
A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined the blood sugar-reducing…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: